Latest period
$578.00M
YoY change
+0.5%
5Y CAGR
+6.6%
Peak year (2014)
$757.00M
Cumulative CapEx
$17.79B
CapEx history chart for Colgate-Palmolive (CL) from 1989 to 2025
Latest: $564.00M
CapEx growth chart for Colgate-Palmolive (CL) from 1989 to 2025
Latest: +0.5%
CapEx history table for Colgate-Palmolive (CL) from 1989 to 2025
| 2025 | $564.00M | +0.5% | +$3.00M | ||
| 2024 | $561.00M | -20.4% | −$144.00M | ||
| 2023 | $705.00M | +1.3% | +$9.00M | ||
| 2022 | $696.00M | +22.8% | +$129.00M | ||
| 2021 | $567.00M | +38.3% | +$157.00M | ||
| 2020 | $410.00M | +22.4% | +$75.00M | ||
| 2019 | $335.00M | -23.2% | −$101.00M | ||
| 2018 | $436.00M | -21.2% | −$117.00M | ||
| 2017 | $553.00M | -6.7% | −$40.00M | ||
| 2016 | $593.00M | -14.2% | −$98.00M | ||
| 2015 | $691.00M | -8.7% | −$66.00M | ||
| 2014 | $757.00M | +13.0% | +$87.00M | ||
| 2013 | $670.00M | +18.6% | +$105.00M | ||
| 2012 | $565.00M | +5.2% | +$28.00M | ||
| 2011 | $537.00M | -2.4% | −$13.00M | ||
| 2010 | $550.00M | -4.3% | −$25.00M | ||
| 2009 | $575.00M | -15.9% | −$109.00M | ||
| 2008 | $684.00M | +17.3% | +$100.90M | ||
| 2007 | $583.10M | +22.4% | +$106.70M | ||
| 2006 | $476.40M | +22.4% | +$87.20M | ||
| 2005 | $389.20M | +11.8% | +$41.10M | ||
| 2004 | $348.10M | +15.2% | +$46.00M | ||
| 2003 | $302.10M | -12.1% | −$41.60M | ||
| 2002 | $343.70M | +1.0% | +$3.50M | ||
| 2001 | $340.20M | -7.2% | −$26.40M | ||
| 2000 | $366.60M | -12.1% | −$50.30M | ||
| 1999 | $416.90M | +1.1% | +$4.70M | ||
| 1998 | $412.20M | -13.9% | −$66.30M | ||
| 1997 | $478.50M | +4.2% | +$19.50M | ||
| 1996 | $459.00M | +6.3% | +$27.20M | ||
| 1995 | $431.80M | +7.7% | +$31.00M | ||
| 1994 | $400.80M | +10.0% | +$36.50M | ||
| 1993 | $364.30M | +14.4% | +$45.80M | ||
| 1992 | $318.50M | +22.2% | +$57.80M | ||
| 1991 | $260.70M | -12.2% | −$36.10M | ||
| 1990 | $296.80M | +41.3% | +$86.80M | ||
| 1989 | $210.00M | — | — |
- 2025$564.00M+0.5%
- 2024$561.00M-20.4%
- 2023$705.00M+1.3%
- 2022$696.00M+22.8%
- 2021$567.00M+38.3%
- 2020$410.00M+22.4%
- 2019$335.00M-23.2%
- 2018$436.00M-21.2%
- 2017$553.00M-6.7%
- 2016$593.00M-14.2%
- 2015$691.00M-8.7%
- 2014$757.00M+13.0%
- 2013$670.00M+18.6%
- 2012$565.00M+5.2%
- 2011$537.00M-2.4%
- 2010$550.00M-4.3%
- 2009$575.00M-15.9%
- 2008$684.00M+17.3%
- 2007$583.10M+22.4%
- 2006$476.40M+22.4%
- 2005$389.20M+11.8%
- 2004$348.10M+15.2%
- 2003$302.10M-12.1%
- 2002$343.70M+1.0%
- 2001$340.20M-7.2%
- 2000$366.60M-12.1%
- 1999$416.90M+1.1%
- 1998$412.20M-13.9%
- 1997$478.50M+4.2%
- 1996$459.00M+6.3%
- 1995$431.80M+7.7%
- 1994$400.80M+10.0%
- 1993$364.30M+14.4%
- 1992$318.50M+22.2%
- 1991$260.70M-12.2%
- 1990$296.80M+41.3%
- 1989$210.00M—
CapEx values are taken from Colgate-Palmolive's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About CapEx at Colgate-Palmolive (CL)
According to Colgate-Palmolive's latest reported financial statements, the company's current CapEx (TTM) is $578.00M. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Colgate-Palmolive (CL) reported CapEx of $564.00M – edged up 0.5% year-over-year.
Through 2020–2025 (5 years), Colgate-Palmolive CapEx delivered a +6.6% annualised rate; with mixed annual results across the window.
Colgate-Palmolive CapEx declined from $757.00M in 2014 to $564.00M in 2025, a 25.5% drawdown.
The highest annual CapEx of $757.00M was reported in 2014. The lowest in the available history was $210.00M in 1989.
Colgate-Palmolive Capital Expenditures by Year
Colgate-Palmolive Capital Expenditures 2025: $564.00M
2025's CapEx for Colgate-Palmolive came in at $564.00M, edged up 0.5% from 2024.
Colgate-Palmolive Capital Expenditures 2024: $561.00M
Colgate-Palmolive posted CapEx of $561.00M in 2024, declined 20.4% below 2023.
Colgate-Palmolive Capital Expenditures 2023: $705.00M
In 2023, Colgate-Palmolive reported CapEx of $705.00M, edged up 1.3% from 2022.
Colgate-Palmolive Capital Expenditures 2022: $696.00M
Colgate-Palmolive CapEx in 2022 was $696.00M, grew 22.8% from 2021.
Colgate-Palmolive Capital Expenditures 2021: $567.00M
Colgate-Palmolive CapEx in 2021 was $567.00M.
See more financial history for Colgate-Palmolive (CL).
Sector peers by CapEx
Consumer Defensive peers of Colgate-Palmolive (CL), ranked by their latest CapEx
| $26.64B | |
| $5.50B | |
| $4.42B | |
| $3.77B | |
| $2.11B | |
| $1.57B | |
| $216.00M | |
| $132.28M |
- $26.64B
- $5.50B
- $4.42B
- $3.77B
- $2.11B
- $216.00M
- $132.28M
Frequently asked questions
Colgate-Palmolive (CL) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation